Literature DB >> 12073119

Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions.

Anwar Hau1, Il Kim, Susan Kattapuram, Francis J Hornicek, Andrew E Rosenberg, Mark C Gebhardt, Henry J Mankin.   

Abstract

The study was undertaken to assess the diagnostic accuracy and clinical usefulness of computed tomography (CT)-guided biopsies and fine needle aspirates of musculoskeletal lesions. The analysis compared the accuracy according to anatomical location, size, type of lesion, and histology. On the basis of the information obtained by reviewing the report of the CT biopsy and comparing it with the final diagnosis for 359 cases, the overall accuracy was determined to be 71%. The accuracy for 101 fine needle aspirations was 63% and for 258 CT-guided core biopsies was 74%. It is of note that the biopsies of 81 pelvic lesions had higher rates of diagnostic accuracy (81%) than those of 278 non-pelvic sites (68%), and especially 94 lesions of the spine (61%). The lowest success rates occurred in 26 patients with infectious diseases (50%). We conclude that these procedures remain the logical and safe choice for diagnostic studies of patients with lesions of the musculoskeletal system.

Entities:  

Mesh:

Year:  2002        PMID: 12073119     DOI: 10.1007/s00256-002-0474-3

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  58 in total

Review 1.  Interventional MDCT.

Authors:  Thomas J Vogl; Joern O Balzer; Martin G Mack; Christopher Herzog
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

2.  2011 Mid-America Orthopaedic Association Dallas B. Phemister Physician in Training Award: Can musculoskeletal tumors be diagnosed with ultrasound fusion-guided biopsy?

Authors:  Jad G Khalil; Michael P Mott; Theodore W Parsons; Trevor R Banka; Marnix van Holsbeeck
Journal:  Clin Orthop Relat Res       Date:  2012-05-30       Impact factor: 4.176

3.  Percutaneous image-guided needle biopsy of rib lesions: a retrospective study of diagnostic outcome in 51 cases.

Authors:  George Chanetsa Jakanani; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-12       Impact factor: 2.199

Review 4.  Imaging findings of Pott's disease.

Authors:  Antonio Rivas-Garcia; Silvana Sarria-Estrada; Carme Torrents-Odin; Lourdes Casas-Gomila; Elisa Franquet
Journal:  Eur Spine J       Date:  2012-06-09       Impact factor: 3.134

Review 5.  Image-guided percutaneous spinal biopsy.

Authors:  Gajan Rajeswaran; Qaiser Malik; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2012-06-04       Impact factor: 2.199

6.  Accuracy of core-needle biopsy after contrast-enhanced ultrasound in soft-tissue tumours.

Authors:  Armanda De Marchi; Elena Maria Brach del Prever; Alessandra Linari; Simona Pozza; Lucia Verga; Ugo Albertini; Marco Forni; Gian Carlo Gino; Alessandro Comandone; Adalberto Maria Brach del Prever; Raimondo Piana; Carlo Faletti
Journal:  Eur Radiol       Date:  2010-06-27       Impact factor: 5.315

7.  Incidence of delayed complications following percutaneous CT-guided biopsy of bone and soft tissue lesions of the spine and extremities: a 2-year prospective study and analysis of risk factors.

Authors:  Ambrose J Huang; Elkan F Halpern; Daniel I Rosenthal
Journal:  Skeletal Radiol       Date:  2012-05-22       Impact factor: 2.199

Review 8.  The multidisciplinary management of osteosarcoma.

Authors:  Noah Federman; Nicholas Bernthal; Fritz C Eilber; William D Tap
Journal:  Curr Treat Options Oncol       Date:  2009-02-24

9.  Investigation of tissue cellularity at the tip of the core biopsy needle with optical coherence tomography.

Authors:  Nicusor Iftimia; Jesung Park; Gopi Maguluri; Savitri Krishnamurthy; Amanda McWatters; Sharjeel H Sabir
Journal:  Biomed Opt Express       Date:  2018-01-18       Impact factor: 3.732

10.  Molecular image-directed biopsies: improving clinical biopsy selection in patients with multiple tumors.

Authors:  Stephanie A Harmon; Michael J Tuite; Robert Jeraj
Journal:  Phys Med Biol       Date:  2016-10-03       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.